ID: ALA605104

Max Phase: Preclinical

Molecular Formula: C22H12N2OS

Molecular Weight: 352.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(Oc2c(-c3ccccc3C#N)sc3ccccc23)cc1

Standard InChI:  InChI=1S/C22H12N2OS/c23-13-15-9-11-17(12-10-15)25-21-19-7-3-4-8-20(19)26-22(21)18-6-2-1-5-16(18)14-24/h1-12H

Standard InChI Key:  KYKNQTSCTKYXGW-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.42Molecular Weight (Monoisotopic): 352.0670AlogP: 6.10#Rotatable Bonds: 3
Polar Surface Area: 56.81Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.71CX LogD: 5.71
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: -1.17

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source